Answers are grounded in this paper and cite their sources.
Phenylketonuria (PKU), the most common inherited metabolic disorder, results from PAH mutations causing hyperphenylalaninemia and brain injury. While low-phenylalanine dietary therapy alleviates neurological symptoms, brain damage mechanisms remain unclear. Using our established PKU mouse model, we performed single-cell RNA sequencing of 38,678 brain cells to elucidate the cellular and molecular mechanisms underlying PKU-associated brain dysfunction. We identified widespread cell-type-specific transcriptomic alterations across major brain cell populations. Oligodendrocytes showed reduced expression of key myelination- and differentiation-related genes, astrocytes exhibited increased expression of synapse-organization genes alongside decreased expression of glial-differentiation genes, microglia displayed upregulation of mitochondrial oxidative-phosphorylation genes, and endothelial cells showed bidirectional dysregulation of genes involved in vascular homeostasis and remodeling. These coordinated changes implicate impaired myelination, altered astrocytic synaptic support, microglial metabolic activation, and neurovascular dysfunction in PKU-associated brain injury. Our findings provide the first comprehensive cellular and molecular map of the PKU-affected brain, offering fresh insights into its complex pathophysiology and guiding development of specific therapeutics beyond dietary management.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: